Business · 02/02/2001Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 125 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) has withdrawn the approval of 125 abbreviated new drug applications (ANDA's) due to repeated non-compliance with annual reporting requirements by the application holders.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →